Lawrence Hineline
Director of Finance/CFO chez INTRA-CELLULAR THERAPIES, INC.
Fortune : - $ au 31/03/2024
Postes actifs de Lawrence Hineline
Sociétés | Poste | Début | Fin |
---|---|---|---|
INTRA-CELLULAR THERAPIES, INC. | Director of Finance/CFO | 05/09/2013 | - |
Treasurer | - | - | |
Comptroller/Controller/Auditor | 29/08/2013 | - | |
Corporate Secretary | 05/09/2013 | 01/09/2014 | |
ITI, Inc. (New York) | Director of Finance/CFO | 01/06/2002 | - |
Corporate Secretary | 01/06/2002 | - |
Historique de carrière de Lawrence Hineline
Anciens postes connus de Lawrence Hineline
Sociétés | Poste | Début | Fin |
---|---|---|---|
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Director of Finance/CFO | 01/06/2002 | 26/09/2013 |
Corporate Secretary | 01/06/2002 | 26/09/2013 | |
Functional Genetics, Inc.
Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Functional Genetics, Inc. operated as a biotechnology company. Its products facilitate simultaneous targeting of multiple co-morbid pathogens with a single drug. The company provided antiviral drugs that demonstrate beneficial activity against various viruses, included HIV, RSV, influenza, hepatitis viruses, herpes and bio-threat pathogens. Functional Genetics was founded in 1987 and was headquartered in Palo Alto, CA. | Director of Finance/CFO | 01/12/2000 | 01/11/2003 |
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Comptroller/Controller/Auditor | 01/01/1989 | 01/01/1993 |
Director of Finance/CFO | 01/01/1993 | 01/01/2000 | |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1984 | 01/01/1984 |
Formation de Lawrence Hineline
University of Maryland | Undergraduate Degree |
University of Maryland Baltimore County | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Opérationnelle
Director of Finance/CFO | 5 |
Corporate Secretary | 3 |
Undergraduate Degree | 2 |
Sectorielle
Health Technology | 4 |
Commercial Services | 3 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
INTRA-CELLULAR THERAPIES, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
North American Vaccine, Inc.
North American Vaccine, Inc. Pharmaceuticals: OtherHealth Technology North American Vaccine, Inc. develops and sells vaccines for the prevention of infectious diseases. The company is based in Columbia, MD. The company was founded by Jeffrey G. Spragens. North American Vaccine was acquired by Baxter International, Inc. on June 27, 2000 for $250.67 million. | Health Technology |
Intra-Cellular Therapies, Inc. /Old/
Intra-Cellular Therapies, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company which focuses on the discovery and clinical development of innovative, small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system. The company's technology addresses diseases of the central nervous system, including schizophrenia, cognition, Parkinson's disease, anxiety, depression, Alzheimer's disease, sleep, and those related to women's health. Its products include clinical development plan for schizophrenia and unique mechanism of action. Intra-Cellular Therapies was founded by Paul Greengard, Sharon Mates and Allen A. Fienberg on May 22, 2001 and is headquartered in New York, NY. | Health Technology |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Commercial Services |
Functional Genetics, Inc.
Functional Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Functional Genetics, Inc. operated as a biotechnology company. Its products facilitate simultaneous targeting of multiple co-morbid pathogens with a single drug. The company provided antiviral drugs that demonstrate beneficial activity against various viruses, included HIV, RSV, influenza, hepatitis viruses, herpes and bio-threat pathogens. Functional Genetics was founded in 1987 and was headquartered in Palo Alto, CA. | Commercial Services |
ITI, Inc. (New York) |
- Bourse
- Insiders
- Lawrence Hineline
- Expérience